Pickup

News

Jul.18, 2025 Notice
Submission of Letter of Intent and Concept Note to the Kenyan Ministry of Health to Accelerate Access to Cefiderocol
Jul.17, 2025 Release
Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
Jul.16, 2025 Release
Conclusion of Investment Agreement with Japan Hydrogen Fund, L.P.
Jul.03, 2025 Release
TRANSITION OF PROMOTIONAL ACTIVITIES FOR ALLERGEN IMMUNOTHERAPY DRUG ACTAIR® IN JAPAN
Jun.30, 2025 Release
Shionogi Submits Supplemental New Drug Application for Ensitrelvir in Japan for the Treatment of COVID-19 in Pediatric Patients Aged 6 Years and Older
News
News List

SHIONOGI Journal

At SHIONOGI, we have passionate colleagues who embody the spirit that has been passed down for over 140 years.
We are excited to share our story of working for patients around the world, society, and our irreplaceable planet.
SHIONOGI Journal

Innovation

Shionogi's Innovation always comes from the passion to provide new value which meet the needs of society and customers, in the healthcare field.
Innovation

Pickup

Sustainability

Shionogi's susutainability programs which toward to become a company that will be needed by stakeholders now and in the future.
Sustainability

Pickup

Learn about SHIONOGI

About Shionogi

Investors

Investor Information

Careers